#wvcusa winner of the Best Prophylactic #Vaccine : Bexsero @Novartis Vaccines and Diagnostics

 
Best Prophylactic vaccine world vaccine congress

The Best Prophylactic Vaccine (approved or in development) category was also open to all international Pharmaceutical, Biotech, Academic and Governmental organizations demonstrating a vaccine candidate that excels in its specific application.

The criteria used to judge this category will be as follows:

  • Vaccine candidate addresses current unmet medical needs
  • Candidate shows significant potential for vast geographical and market reach
  • Candidate possesses a novel mode of action or technology
  • Progress made to do date through clinical trials and / or achieved milestones
  • Advanced efficacy, safety and risk management data where appropriate

Winner: Bexsero – Novartis Vaccines and Diagnostics

 

Novartis_Vaccine_PMS
Judges specific comments on the winner included:

1. First vaccine to come out of a reverse vaccinology approach to antigen discovery. ie from genome to vaccine
2. A long awaited MenB vaccine with impressive clinical results across the majority of MenB strains

Well done Bexsero – Novartis Vaccines and Diagnostics

**********************************************************************

Highly Regarded' recommendation: sanofi pasteur's Clostridium Difficile Vaccine as this candiadate gave the eventual winner a real scare with the final scores, so well done sanofi pasteur.

Leave a Reply

Your email address will not be published. Required fields are marked *